Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Basic Sciences

Phosphorylation of the Mr 170,000 to 180,000 Glycoprotein Specific to Multidrug-resistant Tumor Cells: Effects of Verapamil, Trifluoperazine, and Phorbol Esters

Hirofumi Hamada, Ken-Ichi Hagiwara, Terumi Nakajima and Takashi Tsuruo
Hirofumi Hamada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken-Ichi Hagiwara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terumi Nakajima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Tsuruo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published June 1987
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

An overexpression of plasma membrane glycoprotein with a relative molecular mass (Mr) of 170,000–180,000 is consistently found in different multidrug-resistant human and animal cell lines, although the functional role of the protein in multidrug resistance is not fully understood. It has been reported previously that the Mr 170,000–180,000 glycoprotein is involved, directly or indirectly, in the drug transport mechanism and the proliferation of multidrug-resistant tumor cells. In an attempt to clarify further the function of the Mr 170,000–180,000 glycoprotein, we have studied the phosphorylation state of the protein in intact K562/ADM cells and found that: (a) the protein is phosphorylated in the basal state; (b) verapamil and trifluoperazine, which inhibit the active drug efflux and restore drug sensitivity in resistant cells, caused an increase in the phosphorylation of the Mr 170,000–180,000 glycoprotein; (c) 4β-phorbol 12β-myristate 13α-acetate and 1-oleoyl 2-acetylglycerol enhanced phosphorylation of the protein; (d) the protein was phosphorylated at serine residues; (e) tryptic phosphopeptide mapping of the Mr 170,000–180,000 glycoprotein showed that 4β-phorbol 12β-myristate 13α-acetate treatment induced an increase in phosphorylation at different sites of the protein from those induced by verapamil or trifluoperazine treatment, suggesting that the protein is phosphorylated by an array of complex regulation mechanisms. Phosphorylation of the Mr 170,000–180,000 glycoprotein might play a role in the regulation of processes affecting cellular function in multidrug resistance.

Footnotes

  • ↵1 This work was supported by Grants from the Ministry of Education, Science and Culture, Japan.

  • ↵2 To whom requests for reprints should be addressed.

  • Received October 21, 1986.
  • Revision received February 24, 1987.
  • Accepted February 27, 1987.
  • ©1987 American Association for Cancer Research.
PreviousNext
Back to top
June 1987
Volume 47, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Phosphorylation of the Mr 170,000 to 180,000 Glycoprotein Specific to Multidrug-resistant Tumor Cells: Effects of Verapamil, Trifluoperazine, and Phorbol Esters
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Phosphorylation of the Mr 170,000 to 180,000 Glycoprotein Specific to Multidrug-resistant Tumor Cells: Effects of Verapamil, Trifluoperazine, and Phorbol Esters
Hirofumi Hamada, Ken-Ichi Hagiwara, Terumi Nakajima and Takashi Tsuruo
Cancer Res June 1 1987 (47) (11) 2860-2865;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phosphorylation of the Mr 170,000 to 180,000 Glycoprotein Specific to Multidrug-resistant Tumor Cells: Effects of Verapamil, Trifluoperazine, and Phorbol Esters
Hirofumi Hamada, Ken-Ichi Hagiwara, Terumi Nakajima and Takashi Tsuruo
Cancer Res June 1 1987 (47) (11) 2860-2865;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Basic Sciences

  • c-myc Gene-induced Alterations in Protein Kinase C Expression: A Possible Mechanism Facilitating myc-ras Gene Complementation
  • Identification of a Novel Tumor-associated Mr 110,000 Gene Product in Human Gastric Carcinoma Cells That Is Immunologically Related to Carcinoembryonic Antigen
  • Induction of Tissue-type Plasminogen Activator by Ionizing Radiation in Human Malignant Melanoma Cells
Show more Basic Sciences

Articles

  • c-myc Gene-induced Alterations in Protein Kinase C Expression: A Possible Mechanism Facilitating myc-ras Gene Complementation
  • Identification of a Novel Tumor-associated Mr 110,000 Gene Product in Human Gastric Carcinoma Cells That Is Immunologically Related to Carcinoembryonic Antigen
  • Induction of Tissue-type Plasminogen Activator by Ionizing Radiation in Human Malignant Melanoma Cells
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement